Most of biotech is down mildly today - but TGTX is down big, as usual. It has much further to go - it will go below 4 soon. You know this is true. The data that everyone predicts for both clinical candidates is not forthcoming. You know this is true too. It is best to sell now, and possibly re-buy back in during the summer once it tests new lows closer to 2.
Stock dropped on $0.40 on less than 100,00 shares. The price of TGTX is subject to large price moves with very little volume due to the low float and low liquidity. The only large blocks we have seen in the last 4 months were on the bid buying shares. What you are seeing it fear selling from impatient retail.